Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
2017 ◽
Vol 15
(4)
◽
pp. 445-451
◽
2020 ◽
Vol 29
(3)
◽
pp. 311-326
◽